EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Pharmacodynamic effects of cangrelor in patients with or without STEMI undergoing percutaneous coronary intervention: insights from the POMPEII study

Giuseppe Gargiulo iD, Viviana Narciso, Imma Forzano, Luca Sperandeo, Domenico Simone Castiello, Fiorenzo Simonetti, Lina Manzi, Domenico Florimonte, Mario Enrico Canonico, Marisa Avvedimento, Roberta Paolillo iD, Alessandra Spinelli und 8 weitere

European Heart Journal: Acute Cardiovascular Care · 08.07.2026 · 15 (7) · 524-534

DOI: 10.1093/ehjacc/zuag056 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift European Heart Journal: Acute Cardiovascular Care, online erschienen am 15.04.2026. Verfasst von Giuseppe Gargiulo und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Advanced Biomedical Sciences, Federico II University of Naples, Via S. Pansini 5, Naples 80131, Italy. Hauptthemen laut MEDLINE: Adenosine Monophosphate, Percutaneous Coronary Intervention, ST Elevation Myocardial Infarction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Azienda Ospedaliera Universitaria Federico II, University Federico II.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Cangrelor is approved for oral P2Y12 inhibitor naïve patients undergoing percutaneous coronary intervention (PCI). Pharmacodynamic (PD) investigations in different clinical settings, using various assays, have shown contrasting data in terms of entity of platelet inhibition and rates of high residual platelet reactivity (HRPR). We assessed the PD effects in patients with or without ST elevation myocardial infarction (STEMI) receiving cangrelor during PCI. Methods and results The PharmacOdynaMic effects of cangrelor in PatiEnts wIth acute or chronIc coronary syndrome undergoing percutaneous coronary intervention (POMPEII) registry (NCT04790032) is an investigator-initiated, prospective study assessing PD at four time points with three assays. From March 2021 to June 2024, 126 patients naïve from oral P2Y12 inhibitors underwent PCI with cangrelor [32 with STEMI and 94 without (NSTE-ACS = 30, CCS = 64)]. All STEMI patients switched from cangrelor to ticagrelor, while most patients without STEMI switched to clopidogrel. Inhibition of platelet aggregation (IPA%) during cangrelor infusion was lower in patients with STEMI compared with those without STEMI (LTA 20-μM-ADP 51.5 ± 16.2% vs. 59.7 ± 16.2%; P = 0.017). Conversely, after switching from cangrelor to an oral P2Y12 inhibitor, IPA was greater in patients with STEMI compared with those without STEMI. Rates of HRPR were consistent with lower platelet inhibition in STEMI during cangrelor and greater after its discontinuation compared with patients without STEMI. Within STEMI patients, cangrelor-induced IPA was lower compared with ticagrelor-induced IPA (P = 0.036).

Conclusion

Cangrelor-induced platelet inhibition was lower in patients with STEMI compared with those without STEMI and was lower than that induced by ticagrelor among STEMI patients. The switch from cangrelor to an oral P2Y12 inhibitor exposed patients without STEMI to greater HRPR compared with those with STEMI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenosine MonophosphatePercutaneous Coronary InterventionST Elevation Myocardial InfarctionAgedFemaleHumansMaleMiddle AgedAcute Coronary SyndromePlatelet AggregationPlatelet Aggregation InhibitorsProspective StudiesPurinergic P2Y Receptor AntagonistsRegistriesTicagrelor

Stichwörter der Autor:innen

Acute coronary syndromeCangrelorPercutaneous coronary interventionPharmacodynamicPlatelet inhibitionSTEMI

Substanzen

Adenosine MonophosphatecangrelorPlatelet Aggregation InhibitorsPurinergic P2Y Receptor AntagonistsTicagrelor

Autor:innen und Institutionen

  • Division of Cardiology, Department of Advanced Biomedical Sciences, Federico II University of Naples, Via S. Pansini 5, Naples 80131, Italy.
  • CPC Clinical Research, University of Colorado, Aurora, CO, USA.
  • Cardiovascular Department, Azienda Ospedaliera Regionale 'San Carlo,' Potenza, Italy.
  • Cardiocentro Institute, Ente Ospedaliero Cantonale, Università Della Svizzera Italiana (USI), Lugano, Switzerland.

ORCID-Profile: Giuseppe Gargiulo, Roberta Paolillo, Raffaele Piccolo, Giovanni Esposito

Förderung

  • Azienda Ospedaliera Universitaria Federico II
  • University Federico II

Zitieren

APA

Gargiulo, G., Narciso, V., Forzano, I., Sperandeo, L., Castiello, D. S., Simonetti, F., Manzi, L., Florimonte, D., Canonico, M. E., Avvedimento, M., Paolillo, R., Spinelli, A., Di Serafino, L., Spaccarotella, C. A. M., Franzone, A., Piccolo, R., Stabile, E., Cirillo, P., Valgimigli, M., & Esposito, G. (2026). Pharmacodynamic effects of cangrelor in patients with or without STEMI undergoing percutaneous coronary intervention: insights from the POMPEII study. European Heart Journal: Acute Cardiovascular Care, 15(7), 524-534. https://doi.org/10.1093/ehjacc/zuag056

Vancouver

Gargiulo G, Narciso V, Forzano I, Sperandeo L, Castiello DS, Simonetti F, et al. Pharmacodynamic effects of cangrelor in patients with or without STEMI undergoing percutaneous coronary intervention: insights from the POMPEII study. European Heart Journal: Acute Cardiovascular Care. 2026;15(7):524-534. doi:10.1093/ehjacc/zuag056

BibTeX
@article{Gargiulo2026,
  author = {Gargiulo, Giuseppe and Narciso, Viviana and Forzano, Imma and Sperandeo, Luca and Castiello, Domenico Simone and Simonetti, Fiorenzo and Manzi, Lina and Florimonte, Domenico and Canonico, Mario Enrico and Avvedimento, Marisa and Paolillo, Roberta and Spinelli, Alessandra and Di Serafino, Luigi and Spaccarotella, Carmen Anna Maria and Franzone, Anna and Piccolo, Raffaele and Stabile, Eugenio and Cirillo, Plinio and Valgimigli, Marco and Esposito, Giovanni},
  title = {Pharmacodynamic effects of cangrelor in patients with or without STEMI undergoing percutaneous coronary intervention: insights from the POMPEII study},
  journal = {European Heart Journal: Acute Cardiovascular Care},
  year = {2026},
  volume = {15},
  number = {7},
  pages = {524--534},
  doi = {10.1093/ehjacc/zuag056}
}
Kostenlos starten →